Drug recall · March 30, 2016
Tudorza Pressair recall
Why: Defective Delivery System: Some units have actuation counters set to a number other than 60.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Tudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuation, 60 Metered Doses per Inhaler, Rx Only. Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. Manufactured by: Forest Laboratories, Ireland Limited, Dublin 17 Ireland. Product of Spain. NDC: 0310-0800-60.
- Lots / codes
Lot # 1144394, Expiry: 04/2018; Lot # 1145539, Expiry: 04/2018; Lot # 1145868, Expiry: 05/2018.
- Quantity
- 148,331 Inhalers
- Company
- AstraZeneca Pharmaceuticals LP, Wilmington, DE
- Distribution
- US: Nationwide Including Puerto Rico
- Initiated
- February 5, 2016 · Voluntary: Firm initiated
- Classified
- March 22, 2016
- Reported
- March 30, 2016
- Ended
- June 20, 2017
- How notified
- N/A
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tudorza
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.